Trial Profile
Vasculo-angiogenic effects of cilostazol on endothelial progenitor cells in patients with peripheral arterial occlusive disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2013
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary)
- Indications Cardiovascular disorders; Embolism and thrombosis; Peripheral arterial occlusive disorders
- Focus Biomarker; Pharmacodynamics
- 20 Mar 2013 New trial record
- 11 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.